Don Healey - 15 Feb 2023 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Technology Officer
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
15 Feb 2023
Net transactions value
-$34,327
Form type
4
Filing time
17 Feb 2023, 19:22:15 UTC
Previous filing
14 Feb 2023
Next filing
16 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $34,327 -4,533 -6.4% $7.57 66,568 15 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to fund tax obligations related to PSUs and RSUs that vested in 2022 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 11, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $7.43 to $7.72, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request.